LabGenius, a London-based startup applying AI and “robotic automation” to protein drug discovery, has raised $10 million in Series A funding. The round is led by Lux Capital and Obvious Ventures, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results